| Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy? K Yamanaka, N Chatterjee, MT Hemann, GC Walker PLoS genetics 13 (8), e1006842, 2017 | 88 | 2017 |
| Replication bypass of the acrolein-mediated deoxyguanine DNA-peptide cross-links by DNA polymerases of the DinB family IG Minko, K Yamanaka, ID Kozekov, A Kozekova, C Indiani, ME O’Donnell, ... Chemical research in toxicology 21 (10), 1983-1990, 2008 | 81 | 2008 |
| Novel enzymatic function of DNA polymerase ν in translesion DNA synthesis past major groove DNA− peptide and DNA− DNA cross-links K Yamanaka, IG Minko, K Takata, A Kolbanovskiy, ID Kozekov, RD Wood, ... Chemical research in toxicology 23 (3), 689-695, 2010 | 77 | 2010 |
| A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ K Yamanaka, D Dorjsuren, RL Eoff, M Egli, DJ Maloney, A Jadhav, ... Public Library of Science 7 (10), e45032, 2012 | 44 | 2012 |
| Structure–activity relationship studies of naphthol AS-E and its derivatives as anticancer agents by inhibiting CREB-mediated gene transcription BX Li, K Yamanaka, X Xiao Bioorganic & medicinal chemistry 20 (23), 6811-6820, 2012 | 38 | 2012 |
| The cell-penetrating peptide, Pep-1, has activity against intracellular chlamydial growth but not extracellular forms of Chlamydia trachomatis N Park, K Yamanaka, D Tran, P Chandrangsu, JC Akers, JC de Leon, ... Journal of antimicrobial chemotherapy 63 (1), 115-123, 2009 | 27 | 2009 |
| Role of high-fidelity Escherichia coli DNA polymerase I in replication bypass of a deoxyadenosine DNA-peptide cross-link K Yamanaka, IG Minko, SE Finkel, MF Goodman, RS Lloyd Journal of bacteriology 193 (15), 3815-3821, 2011 | 24 | 2011 |
| Replication of the 2,6-Diamino-4-hydroxy-N5-(methyl)-formamidopyrimidine (MeFapy-dGuo) Adduct by Eukaryotic DNA Polymerases PP Christov, K Yamanaka, JY Choi, K Takata, RD Wood, FP Guengerich, ... Chemical research in toxicology 25 (8), 1652-1661, 2012 | 22 | 2012 |
| Leukotriene biosynthesis inhibitor MK886 impedes DNA polymerase activity A Ketkar, MK Zafar, L Maddukuri, K Yamanaka, S Banerjee, M Egli, ... Chemical research in toxicology 26 (2), 221-232, 2013 | 20 | 2013 |
| C21orf57 is a human homologue of bacterial YbeY proteins A Ghosal, C Köhrer, VMP Babu, K Yamanaka, BW Davies, AI Jacob, ... Biochemical and biophysical research communications 484 (3), 612-617, 2017 | 16 | 2017 |
| Functions of translesion DNA polymerases: implications for cancer risk and opportunities as therapeutic targets K Yamanaka, RS Lloyd DNA Repair and Cancer: Bench to Clinic. Science Publishers, 2013 | 5 | 2013 |
| Non mutagenic and mutagenic DNA damage tolerance S D'Souza, K Yamanaka, GC Walker Cell Cycle 15 (3), 314-315, 2016 | 4 | 2016 |
| Identification of the potential inhibitors of DNA polymerase kappa CB Sullivan, IG Minko, K Yamanaka, AK McCullough, S Lloyd Cancer Research 74 (19_Supplement), 3235-3235, 2014 | | 2014 |
| Molecular targeting of translesion synthesis DNA polymerases for novel combination chemotherapy K Yamanaka Oregon Health & Science University, 2012 | | 2012 |
| Small Molecule Inhibitors of DNA Polymerase Kappa K Yamanaka, RL Eoff, M Egli, D Dorjsuren, A Jadhav, A Simeonov, ... ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 51 (7), 716-716, 2010 | | 2010 |
